APA (7th ed.) Citation

KF, R., FJ, M., SP, B., T, K., BG, C., RM, M., . . . RM, A. (2024). AERIFY-1/2: Two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD. ERJ open research, 10(5), . https://doi.org/10.1183/23120541.00718-2023

Chicago Style (17th ed.) Citation

KF, Rabe, et al. "AERIFY-1/2: Two Phase 3, Randomised, Controlled Trials of Itepekimab in Former Smokers with Moderate-to-severe COPD." ERJ Open Research 10, no. 5 (2024). https://doi.org/10.1183/23120541.00718-2023.

MLA (9th ed.) Citation

KF, Rabe, et al. "AERIFY-1/2: Two Phase 3, Randomised, Controlled Trials of Itepekimab in Former Smokers with Moderate-to-severe COPD." ERJ Open Research, vol. 10, no. 5, 2024, https://doi.org/10.1183/23120541.00718-2023.